Restricted Compounds definition

Restricted Compounds has the respective meaning set forth in this Section 20.4.4(c):
Sample 1
Restricted Compounds means any and all of: (A)(I) (+)-alpha-Methylbenzeneethanamine, also known as “amphetamine”, (II) carbamazepine (5H-Dibenz{b,f}azepine-5-carboxyamide), (III) guanfacine (N-(Aminoiminomethyl)-2,6-dichlorobenzeneacetamide), (IV) lanthanum, and (V) mesalamine (5-Amino-2-hydroxybenzoic acid), (B) any isomers, salts, solvates, hydrates, polymorphs, esters, prodrugs, or metabolites of clause (A), and (C) any compound involving forming or breaking a bond or bonds with any of clause (A) or (B) where at least one prophylactic, therapeutic or diagnostic indication of such compound and/or its metabolite is substantially the same as that of any of clause (A) or (B), but excluding 10,11-Dihydro-10-oxo-5H-debenz[b,f]azepine-5-carboxamide, also known as “oxcarbazepine”.
Sample 1Sample 2
Restricted Compounds has the meaning set forth in Section 2.10. 1.91. “[***]. 1. 92. “[***].
Sample 1

Examples of Restricted Compounds in a sentence

  • In the event that the Intent to Access Other Restrictions include any Compounds or Analogs on which the Company is precluded from conducting the Lead Seeking Activities in connection with the Collaboration, such Compounds and Analogs shall be deemed Restricted Compounds.

  • Notwithstanding the foregoing restriction, Pfizer may use such Restricted Compounds as a reference standard only (and may make such Restricted Compounds to the extent necessary for such use), provided; Pfizer shall not publish any data resulting from any use of the Restricted Compounds.

  • Provision of public facilities within the campground may cause conflict with other users of the park and result in excessive demand on facilities.The level of service is not changing – visitors to the park will still need to be self-sufficient 5.

  • Cortex shall be permitted to provide to third parties information with respect to Cortex Restricted Compounds, provided such information was not developed as part of the Research.

  • Such compounds which meet the requirements shall remain Restricted Compounds and any screened compounds which do not meet the requirements other than Organon Compounds, shall become Unrestricted Compounds.

  • Selection of Leads for (Pre)clinical Development ------------------------------------------------ Organon shall select Restricted Compounds that are most promising for the Selection Phase and subsequently the XXXX Phase.

  • Organon shall own exclusively the Restricted Compounds other than Cortex Compounds.

  • A summary of the incidence of symptomatic EAH in five events is depicted in table 2.9.Table 2.9.: The incidence of symptomatic EAH in distance running events (by event and study reference, type of study, number of participants (n), race distance (km), incidence/1000 participants abcd (IR) and absolute risk (AR) ofnumber of participants abcd/1 incident)Type: Type of studyN: Number of participants Km: Race distanceIR: Incidence rate of symptomatic EAH (rate/1000 participants abcd)AR: Absolute risk - no.

  • Creditors must review the Plan itself for a complete understanding of the Plan and disclosure of its terms.

  • At the time of such approval of selected compounds, such compounds shall be designated as "Restricted Compounds," provided that such compounds have not been previously designated as Excluded Compounds under Section 4.10.


More Definitions of Restricted Compounds

Restricted Compounds shall have the meaning assigned to it in Section 4.4.
Sample 1
Restricted Compounds has the meaning set forth in Section 2.10.
Sample 1
Restricted Compounds means: Organon Compounds; compounds which are still under investigation in the Research pursuant to Section 3.3 below; Research Collaboration Compounds that are not AMPAkines; those Research Collaboration Compounds and Cortex Compounds which have entered the Selection Phase and those compounds which are developed and commercialized pursuant to Section 4.5 below.
Sample 1

Related to Restricted Compounds

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Licensed Compound means a TAK-385 Licensed Compound or a TAK-448 Licensed Compound.

  • Compounds means any or all of the following chemicals, as the context requires:

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Exempt compound means the same as defined in Rule 2.

  • Product Candidate means each biological and drug candidate, compound or other device or product being developed, labeled, manufactured, marketed, sold and/or distributed by the Company or a Company Subsidiary, or regarding which the Company or a Company has rights, and including any such biological and drug candidate, compound or product that has received Marketing Approval.

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Diagnostic Product means an assemblage of reagents, including but not limited to reagents packaged in the form of a kit, useful in performing a Licensed Service.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications, or derivatives thereof, but excluding single variable domains (heavy or light) of such antibodies.

  • Competing Product means [***].

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Competing Products means any product or service in existence or under development that competes with any product or service of the Company Group about which the Participant obtained Confidential Information or for which the Participant provided advisory services or had sales, origination, marketing, production, distribution, research or development responsibilities in the last twenty-four (24) months of employment with the Company Group.

  • Commercialized shall have corresponding meanings.

  • geographical indication , in relation to goods, means an indication which identifies such goods as agricultural goods, natural goods or manufactured goods as originating, or manufactured in the territory of a country, or a region or locality in that territory, where a given quality, reputation or other characteristic of such goods is essentially attributable to its geographical origin and in case where such goods are manufactured goods one of the activities of either the production or of processing or preparation of the goods concerned takes place in such territory, region or locality, as the case may be.

  • Commercializing means to engage in Commercialization and “Commercialized” has a corresponding meaning.

  • Restricted Territory means the United States of America.

  • Manufacturing Technology means any and all patents, patent applications, know-how, and all intellectual property rights associated therewith that are owned or controlled by Licensor, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno-associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Opioid antagonist means a drug that binds to opioid

  • Collaborating physician means the physician who,

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.